The young founder teaching big pharma a new way to reverse aging
LEVITY - 21-Nov-2025Targeted epigenetic editing could deliver durable, precise therapies for aging-related diseases
Join the club for FREE to access the whole archive and other member benefits.
Targeted epigenetic editing could deliver durable, precise therapies for aging-related diseases
CRISPR therapy cut LDL and triglycerides by roughly 50% after a single infusion
Early results show hope for future hearing loss treatments
New treatment slows Huntington’s by 75%, offering patients hope of longer, better lives
New “vPE” tool cuts DNA errors 465-fold, boosting accuracy for future cell therapies
This could help treat many diseases by fixing problems at the source
Special techniques can improve body repair, energy, and reduce age-related illness
This may be a way to treat lifestyle diseases at the root, biologically and sustainably
Scientists restore mitochondrial function using precise, CRISPR-free gene editing tools
SB-007 enters phase 1/2 trials to restore vision in Stargardt disease using novel splicing tech
New tool guides RNA to injury sites in neurons, offering hope for neurodegenerative therapies
Magnetic fields trigger gene expression in cells via ROS-sensitive nanoparticle interfaces
Therapy cut blood sugar by >200 mg/dL & doubled insulin with 5x less GLP-1 than standard drugs
More testing and funding are needed before it can be used in people
ENTER system bypasses cell traps to deliver gene therapies precisely and safely
Verve’s one-time gene therapy could end daily cholesterol meds
Ancient DNA and gene editing revive the Ice Age predator after 10,000 years
A stealthy Shanghai startup pioneers a longer-lasting, safer alternative to mRNA and gene therapies
The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease
Scientists aim to create cold-adapted elephants to restore Arctic ecosystems
Verve regains full rights to its liver disease program as it moves forward independently
Regeneron’s DB-OTO offers new hope for genetic hearing loss
A groundbreaking trial shows how early genetic treatment can transform vision and improve lives
The partnership adds BIOTEM’s antibodies to Bio-ReCell’s kits to boost cell therapy precision and scale
Transforming lives with a groundbreaking cure for sickle cell disease